Shopping Cart 0
Cart Subtotal
AED 0

Merial Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Merial Ltd (Merial), a subsidiary of Boehringer Ingelheim GmbH, is an animal healthcare center that produces and markets pharmaceutical products and vaccines. The center offers products for dogs, cats, beef, dairy, equine, and swine to improve their health and performance. It develops specifically formulated products for cats such as flea and tick control, and vaccines for leukemia, rabies and other feline diseases. Merial offers research and development for biologicals drugs and pharmaceuticals vaccines. The center works with various biotechnology companies to develop new products. It serves beef, dairy producers, and veterinarians in the US. Merial is headquartered in Duluth, Georgia, the US.

Merial Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 4

Merial Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8

Merial Ltd, Pharmaceuticals & Healthcare, Deal Details 9

Asset Purchase 9

Merial Acquires Two Equine Health Products from Bayer HealthCare 9

Merial to Acquire Manufacturing Facility from Merck 10

Licensing Agreements 10

Vivalis Enters Into Licensing Agreement With Merial For EB66 Cell Line 10

GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 11

Centegen Enters Into Licensing Agreement With Merial For CEN-102 12

Merial Ltd-Key Competitors 13

Key Employees 14

Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

Merial Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Merial Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7


List Of Table

List of Tables

Merial Ltd, Pharmaceuticals & Healthcare, Key Facts 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Merial Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8

Merial Acquires Two Equine Health Products from Bayer HealthCare 9

Merial to Acquire Manufacturing Facility from Merck 10

Vivalis Enters Into Licensing Agreement With Merial For EB66 Cell Line 10

GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 11

Centegen Enters Into Licensing Agreement With Merial For CEN-102 12

Merial Ltd, Key Competitors 13

Merial Ltd, Key Employees 14

Merial Ltd, Other Locations 15

Merial Ltd, Subsidiaries 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Merial Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Merial Ltd (Merial), a subsidiary of Boehringer Ingelheim GmbH, is an animal healthcare center that produces and markets pharmaceutical products and vaccines. The center offers products for dogs, cats, beef, dairy, equine, and swine to improve their health and performance. It develops specifically formulated products for cats such as flea and tick control, and vaccines for leukemia, rabies and other feline diseases. Merial offers research and development for biologicals drugs and pharmaceuticals vaccines. The center works with various biotechnology companies to develop new products. It serves beef, dairy producers, and veterinarians in the US. Merial is headquartered in Duluth, Georgia, the US.

Merial Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 4

Merial Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8

Merial Ltd, Pharmaceuticals & Healthcare, Deal Details 9

Asset Purchase 9

Merial Acquires Two Equine Health Products from Bayer HealthCare 9

Merial to Acquire Manufacturing Facility from Merck 10

Licensing Agreements 10

Vivalis Enters Into Licensing Agreement With Merial For EB66 Cell Line 10

GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 11

Centegen Enters Into Licensing Agreement With Merial For CEN-102 12

Merial Ltd-Key Competitors 13

Key Employees 14

Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

Merial Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Merial Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7


List Of Table

List of Tables

Merial Ltd, Pharmaceuticals & Healthcare, Key Facts 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Merial Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Merial Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Merial Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8

Merial Acquires Two Equine Health Products from Bayer HealthCare 9

Merial to Acquire Manufacturing Facility from Merck 10

Vivalis Enters Into Licensing Agreement With Merial For EB66 Cell Line 10

GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 11

Centegen Enters Into Licensing Agreement With Merial For CEN-102 12

Merial Ltd, Key Competitors 13

Merial Ltd, Key Employees 14

Merial Ltd, Other Locations 15

Merial Ltd, Subsidiaries 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Merial Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.